Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
27
EVH Quote, Financials, Valuation and Earnings
Last price:
$4.14
Seasonality move
:
2.19%
Day range:
$3.94 - $4.11
52-week range:
$3.50 - $12.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.23x
P/B ratio:
0.55x
Volume:
2.9M
Avg. volume:
4.8M
1-year change:
-64.77%
Market cap:
$464.3M
Revenue:
$2.6B
EPS (TTM):
-$1.57
Analysts' Opinion
-
Consensus RatingEvolent Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.18, Evolent Health, Inc. has an estimated upside of 144.68% from its current price of $4.02.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $4.02.
Fair Value
-
According to the consensus of 11 analysts, Evolent Health, Inc. has 144.68% upside to fair value with a price target of $10.18 per share.
EVH vs. S&P 500
-
Over the past 5 trading days, Evolent Health, Inc. has overperformed the S&P 500 by 0.21% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Evolent Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Evolent Health, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Evolent Health, Inc. reported revenues of $479.5M.
Earnings Growth
-
Evolent Health, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Evolent Health, Inc. reported earnings per share of -$0.24.
Enterprise value:
1.4B
EV / Invested capital:
0.73x
Price / LTM sales:
0.23x
EV / EBIT:
305.50x
EV / Revenue:
0.68x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-20.48x
Price / Operating cash flow:
11.17x
Enterprise value / EBITDA:
12.60x
Gross Profit (TTM):
$277.4M
Return On Assets:
-5.08%
Net Income Margin (TTM):
-6.24%
Return On Equity:
-13.6%
Return On Invested Capital:
-6.63%
Operating Margin:
0.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.8B | $2.5B | $2.1B | $621.4M | $479.5M | |
| Gross Profit | $326.3M | $274.3M | $277.4M | $51M | $75.9M | |
| Operating Income | $19.6M | $10.9M | $4.6M | -$12.3M | $658K | |
| EBITDA | $149.4M | $130.7M | $111.6M | $17.4M | $27.5M | |
| Diluted EPS | -$1.03 | -$0.91 | -$1.57 | -$0.27 | -$0.24 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $478.2M | $393.8M | $638.8M | $544M | $570.1M | |
| Total Assets | $1.3B | $1.8B | $2.7B | $2.5B | $2.5B | |
| Current Liabilities | $367.2M | $382M | $615.3M | $523.7M | $429.9M | |
| Total Liabilities | $646M | $903M | $1.6B | $1.5B | $1.6B | |
| Total Equity | $607.5M | $856.1M | $1.1B | $1B | $842.2M | |
| Total Debt | $268.3M | $470.3M | $815.2M | $816.2M | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $88.9M | $134.4M | -$36.2M | $18.7M | $15.8M | |
| Cash From Investing | -$413.9M | -$49.1M | -$102.3M | -$19.7M | -$8.8M | |
| Cash From Financing | $354.8M | -$181.9M | $154.1M | -$9M | -$41.8M | |
| Free Cash Flow | $55.5M | $109.6M | -$68.7M | $12.4M | $6.9M | |
EVH
Sector
Market Cap
$464.3M
$28.1M
Price % of 52-Week High
32.05%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
-1.32%
-1.49%
1-Year Price Total Return
-63.25%
-17.13%
Beta (5-Year)
0.276
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
14.67%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.03
200-day SMA
Sell
Level
$8.38
Bollinger Bands (100)
Sell
Level
4.97 - 9.37
Chaikin Money Flow
Sell
Level
-77.8M
20-day SMA
Sell
Level
$4.04
Relative Strength Index (RSI14)
Sell
Level
37.00
ADX Line
Sell
Level
38.84
Williams %R
Neutral
Level
-26.3158
50-day SMA
Sell
Level
$5.33
MACD (12, 26)
Sell
Level
-0.32
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
17.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0295)
Sell
CA Score
(Annual)
Level (-0.5545)
Sell
Beneish M-Score
(Annual)
Level (-2.1966)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.4998)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Stock Forecast FAQ
In the current month, EVH has received 11 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVH average analyst price target in the past 3 months is $10.18.
-
Where Will Evolent Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Evolent Health, Inc. share price will rise to $10.18 per share over the next 12 months.
-
What Do Analysts Say About Evolent Health, Inc.?
Analysts are divided on their view about Evolent Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evolent Health, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Evolent Health, Inc.'s Price Target?
The price target for Evolent Health, Inc. over the next 1-year time period is forecast to be $10.18 according to 11 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EVH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Evolent Health, Inc. is a Buy. 11 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EVH?
You can purchase shares of Evolent Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evolent Health, Inc. shares.
-
What Is The Evolent Health, Inc. Share Price Today?
Evolent Health, Inc. was last trading at $4.14 per share. This represents the most recent stock quote for Evolent Health, Inc.. Yesterday, Evolent Health, Inc. closed at $4.02 per share.
-
How To Buy Evolent Health, Inc. Stock Online?
In order to purchase Evolent Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get EVH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EVH
Sector
P/E ratio
--
23.89x
PEG ratio
-0.04x
-0.01x
P/B ratio
0.55x
1.81x
Price / LTM sales
0.23x
1.59x
Growth Metrics
EVH
Sector
Revenue growth
-22.83%
4.62%
Earnings growth
13.17%
11.06%
Revenue (5-year growth)
24.73%
6.5%
Earnings forecast
$0.10
-$0.21
Profitability
EVH
Sector
Profitability FY 2024
$247.9M
$3.6M
Return on invested capital
-6.63%
-31.84%
Return on assets
-5.08%
-27.96%
Return on equity
-13.6%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Feb
5
Balance Sheet
EVH
Sector
Total cash
$140.3M
$26.4M
Short term investments
--
$25.7M
Total assets
$2.5B
$76.9M
Long term debt
$1.1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
